[1]
Waitzberg, A.F.L. et al. 2026. Immunoexpression of markers related to the human epidermal growth factor receptor-type 2 (HER2) pathway in cases of pure positive HER2 breast carcinoma treated with trastuzumab. Mastology. 35, suppl.1 (Feb. 2026). DOI:https://doi.org/10.29289/259453942025V35S1045.